Entrada Therapeutics, Inc.
Total Trades
107
Buys
9
Sells
75
Largest Trade
N/A
Insiders
10
Institutional Funds
75
Inst. Value
$1M+
Activist Filings
19
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dowden Nathan J | COO | SELL | $100K–$500K | 16K | $15.42 | Jun 22, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $13.71 | May 1, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $18.01 | Apr 19, 2023 |
| Sethuraman Natarajan | Chief Scientific O… | SELL | $50K–$100K | 4K | $18.00 | Apr 19, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $14.72 | Mar 29, 2023 |
| WENTWORTH KORY JAMES | CFO | GRANT | N/A | 28K | — | Mar 3, 2023 |
| WENTWORTH KORY JAMES | CFO | SELL | $15K–$50K | 2K | $10.53 | Mar 3, 2023 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.56 | Mar 3, 2023 |
| KREHER NERISSA | Chief Medical Offi… | GRANT | N/A | 28K | — | Mar 3, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $12.00 | Mar 2, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $12.00 | Jan 30, 2023 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $15.02 | Jan 10, 2023 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $50K–$100K | 5K | $13.45 | Jan 3, 2023 |
| Doshi Dipal | President and CEO | SELL | $100K–$500K | 15K | $15.02 | Dec 29, 2022 |
| WENTWORTH KORY JAMES | CFO | SELL | $50K–$100K | 5K | $18.95 | Dec 12, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 5K | $2.10 | Dec 12, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 3K | $2.10 | Dec 6, 2022 |
| WENTWORTH KORY JAMES | CFO | SELL | $50K–$100K | 3K | $18.19 | Dec 6, 2022 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $13.91 | Nov 30, 2022 |
| WENTWORTH KORY JAMES | CFO | SELL | $1K–$15K | 200 | $18.10 | Nov 18, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | <$1K | 200 | $2.10 | Nov 18, 2022 |
| Dowden Nathan J | COO | SELL | $50K–$100K | 2K | $24.05 | Nov 2, 2022 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | $15K–$50K | 13K | $2.10 | Oct 27, 2022 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $100K–$500K | 13K | $21.27 | Oct 27, 2022 |
| Dowden Nathan J | COO | SELL | $100K–$500K | 9K | $20.77 | Oct 27, 2022 |
| Doshi Dipal | President and CEO | SELL | $100K–$500K | 14K | $20.80 | Oct 27, 2022 |
| Dowden Nathan J | COO | SELL | $100K–$500K | 6K | $18.66 | Oct 24, 2022 |
| Doshi Dipal | President and CEO | SELL | $100K–$500K | 6K | $18.64 | Oct 24, 2022 |
| Doshi Dipal | President and CEO | SELL | $100K–$500K | 11K | $15.25 | Sep 28, 2022 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | $15K–$50K | 9K | $2.10 | Sep 28, 2022 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $100K–$500K | 9K | $15.29 | Sep 28, 2022 |
| Dowden Nathan J | COO | SELL | $15K–$50K | 2K | $15.45 | Sep 28, 2022 |
| Doshi Dipal | President and CEO | SELL | $50K–$100K | 4K | $15.10 | Sep 23, 2022 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | $1K–$15K | 4K | $2.10 | Sep 23, 2022 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $50K–$100K | 4K | $15.08 | Sep 23, 2022 |
| Dowden Nathan J | COO | SELL | $50K–$100K | 4K | $15.11 | Sep 23, 2022 |
| Doshi Dipal | President and CEO | SELL | $1K–$15K | 200 | $15.04 | Sep 19, 2022 |
| Dowden Nathan J | COO | SELL | $1K–$15K | 100 | $15.01 | Sep 19, 2022 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | <$1K | 106 | $2.10 | Sep 19, 2022 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $1K–$15K | 106 | $15.01 | Sep 19, 2022 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $15.12 | Sep 12, 2022 |
| KREHER NERISSA | Chief Medical Offi… | EXERCISE | $1K–$15K | 2K | $2.10 | Sep 12, 2022 |
| KREHER NERISSA | Chief Medical Offi… | SELL | $15K–$50K | 2K | $15.11 | Sep 12, 2022 |
| Dowden Nathan J | COO | SELL | $15K–$50K | 2K | $15.11 | Sep 12, 2022 |
| Doshi Dipal | President and CEO | SELL | $15K–$50K | 2K | $12.72 | Aug 31, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 1K | $2.10 | Aug 26, 2022 |
| WENTWORTH KORY JAMES | CFO | SELL | $50K–$100K | 5K | $13.78 | Aug 26, 2022 |
| WENTWORTH KORY JAMES | CFO | SELL | $100K–$500K | 12K | $13.08 | Aug 23, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | $1K–$15K | 6K | $2.10 | Aug 23, 2022 |
| WENTWORTH KORY JAMES | CFO | EXERCISE | <$1K | 300 | $2.10 | Aug 18, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 75 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| 5AM Venture Management, LLC | 4.1M | $1M+ | SH |
| VANGUARD GROUP INC | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 556K | $1M+ | SH |
| STATE STREET CORP | 509K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 363K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 311K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 253K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 252K | $1M+ | SH |
| ROYCE & ASSOCIATES LP | 247K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 221K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 181K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 111K | $1M+ | SH |
| MOORE CAPITAL MANAGEMENT, LP | 105K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 89K | $500K+ | SH |
| AMERICAN CENTURY COMPANIES INC | 75K | $500K+ | SH |
| BlackRock, Inc. | 70K | $500K+ | SH |
| BARCLAYS PLC | 67K | $500K+ | SH |
| CANTOR FITZGERALD, L. P. | 57K | $500K+ | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 57K | $500K+ | SH |
| Nan Fung Group Holdings Ltd | 49K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 25, 2025
5.0%
1.9M shares
SC 13D/A · Nov 18, 2025
7.8%
3.0M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Nov 14, 2025
0.9%
361K shares
T. Rowe Price Associates, Inc.
SC 13G/A · Aug 14, 2025
6.8%
2.6M shares
SC 13G/A · Aug 14, 2025
4.0%
1.5M shares
SC 13G/A · May 14, 2025
5.6%
2.1M shares
SC 13G/A · Feb 14, 2025
6.9%
2.6M shares
SC 13G · Feb 14, 2025
5.6%
2.1M shares
SC 13G · Feb 4, 2025
5.3%
2.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
8.2%
3.0M shares
SC 13D/A · Jun 26, 2024
13.2%
4.9M shares
SC 13G/A · Feb 14, 2024
3.8%
1.3M shares
SC 13G/A · Feb 14, 2024
8.2%
2.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
9.0%
3.0M shares
SC 13G/A · Feb 14, 2023
5.9%
1.9M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
9.6%
3.0M shares
SC 13G · Feb 14, 2022
6.3%
2.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2022
6.4%
2.0M shares
SC 13G · Feb 14, 2022
9.0%
2.8M shares